SCHEMBL1346915

SCHEMBL1346915

CC(=O)Oc1ccc(C2Cc3ccc(OC(C)=O)cc3C(Cc3ccccc3F)C2C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
OPRM1 P35372 3/20 0.40
OPRD1 P41143 2/20 0.39
OPRK1 P41145 1/20 0.39
SCN3A Q9NY46 8/20 0.35
MAOB P27338 2/20 0.34
KCNH2 Q12809 6/20 0.33
ALDH1A1 P00352 1/20 0.33
HSP90AA1 P07900 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
MDM2 Q00987 1/20 0.33
SCN1A P35498 1/20 0.33
SCN4A P35499 1/20 0.33
SCN7A Q01118 1/20 0.33
SCN5A Q14524 1/20 0.33
SCN9A Q15858 1/20 0.33
SCN2A Q99250 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1347055 0.90 OPRM1 (0.42) NQO2MTNR1AMTNR1BOPRM1OPRD1
SCHEMBL1344585 0.89 NQO2 (0.40) NQO2MTNR1AMTNR1BOPRM1OPRD1
SCHEMBL1346637 0.85 NQO2 (0.46) NQO2MTNR1AMTNR1BOPRM1MAOB
SCHEMBL1346297 0.81 SHBG (0.42) NQO2MTNR1AMTNR1BALDH1A1
SCHEMBL1347419 0.81 SHBG (0.42) NQO2MTNR1AMTNR1BALDH1A1
SCHEMBL1346967 0.81 SHBG (0.42) NQO2MTNR1AMTNR1BALDH1A1
SCHEMBL1344576 0.78 NQO2 (0.42) NQO2MTNR1AMTNR1BOPRM1OPRD1
SCHEMBL1345970 0.78 NQO2 (0.39) NQO2MTNR1AMTNR1BMAOB
SCHEMBL1346410 0.75 SIGMAR1 (0.39) OPRM1OPRD1OPRK1SCN3AMAOB
SCHEMBL1344496 0.74 NQO2 (0.41) NQO2MTNR1AMTNR1BOPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406206-B1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD OSS BV (NL) 2013-01-30 EP disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES VHL, BRCA1, TPH2 NQO2 1888/4885MTNR1A 133/4885MTNR1B 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.